Confirmation of an association between a polymorphism in exon 3 of the low‐density lipoprotein receptor‐related protein gene and Alzheimer's disease
C766T, a polymorphism in exon 3 of the gene for the low-density lipoprotein receptor-related
protein (LRP), was found to be associated with late-onset Alzheimer's disease (AD). We
developed a PCR-restriction enzyme—based assay to analyze this allele in 234 AD patients
and 103 controls. We confirmed that the LRP C766T polymorphism was in disequilibrium
with AD—the C/C genotype was present in 76% of AD patients and 60% of controls (p<
0.01); however, the LRP polymorphism did not influence age at onset of AD.
protein (LRP), was found to be associated with late-onset Alzheimer's disease (AD). We
developed a PCR-restriction enzyme—based assay to analyze this allele in 234 AD patients
and 103 controls. We confirmed that the LRP C766T polymorphism was in disequilibrium
with AD—the C/C genotype was present in 76% of AD patients and 60% of controls (p<
0.01); however, the LRP polymorphism did not influence age at onset of AD.
C766T, a polymorphism in exon 3 of the gene for the low-density lipoprotein receptor-related protein (LRP), was found to be associated with late-onset Alzheimer's disease (AD). We developed a PCR-restriction enzyme—based assay to analyze this allele in 234 AD patients and 103 controls. We confirmed that the LRP C766T polymorphism was in disequilibrium with AD—the C/C genotype was present in 76% of AD patients and 60% of controls (p < 0.01); however, the LRP polymorphism did not influence age at onset of AD.
American Academy of Neurology